Effectiveness and Safety of rhIGF-1 Therapy in Children: The European Increlex® Growth Forum Database Experience

Publisher： Karger

E-ISSN： 1663-2826|83|5|345-357

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.83, Iss.5, 2015-03, pp. : 345-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Baseline IGF-I Levels Determine Insulin Secretion and Insulin Sensitivity during the First Year on Growth Hormone Therapy in Children Born Small for Gestational Age. Results from a North European Multicentre Study (NESGAS)

By  

Hormone Research in Paediatrics, Vol. 80, Iss. 1, 2013-07 ,pp. : 38-46

Karger

Access to resources Recommend Favorite

Evolution of IGF-1 in Children Born Small for Gestational Age and with Growth Retardation, Treated by Growth Hormone Adapted to IGF-1 Levels after 1 Year

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 6, 2011-12 ,pp. : 419-427

Karger

Access to resources Recommend Favorite

Safety of Growth Hormone Treatment of Children with Idiopathic Short Stature: The US Experience

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 3, 2011-09 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Insulin-Like Growth Factor-I Treatment in Primary Growth Hormone Insensitivity: Effect of Recombinant Human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-Binding Protein-3 Complex

By  

Hormone Research in Paediatrics, Vol. 73, Iss. 2, 2010-02 ,pp. : 140-147

Karger

Access to resources Recommend Favorite

Postprandial Hyperglycemia Corrected by IGF-I (Increlex®) in Laron Syndrome

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 3, 2012-09 ,pp. : 193-200

Karger

Access to resources Recommend Favorite